FBR Capital Reiterates Market Perform Following Five Below (FIVE) 1Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
MKM Partners Raise Price Target on Five Below (FIVE) Following 1Q15 Results
June 4, 2015 10:39 AM EDTMKM Partners reiterates a Buy rating on Five Below (NASDAQ: FIVE), and raised the price target to $50.00 (from $41.00), following 1Q15. EPS increased 14% to $0.08 and beat MKM Partners estimate by $0.01. Same-store sales increased 1.7%.
Analyst Patrick McKeever commented, "The numbers were modest relative to trend, given a tough... More
Pre-Open Stock Movers 06/04: (BRLI) (AVEO) (FIVE) Higher; (MCP) (DRWI) (OPK) Lower (more...)
June 4, 2015 9:27 AM EDTBio-Reference Laboratories, Inc. (NASDAQ: BRLI) 42.2% HIGHER; OPKO Health (NYSE:... More
After-Hours Stock Movers 06/03: (FIVE) (FEYE) (EYES) Higher; (DRWI) (SGMO) (BLUE) Lower (more...)
June 3, 2015 5:58 PM EDTDragonWave (NASDAQ: DRWI) 17.4% LOWER; announced updated revenue expectations of approximately $27 million for its first quarter of fiscal year 2016, ended May 31, 2015. Revenue is lower than expected because shipments associated with orders received did not make the first quarter cut off. These shipments are now expected to occur in the second quarter fiscal year 2016. *** Consensus estimates call for Q1 revenue of $32 million.
Sangamo Biosciences (NASDAQ: SGMO) 7.6% LOWER; disclosed the following: On May 29, 2015, Dr. Philip D. Gregory, senior vice president, research and... More
Five Below (FIVE) Tops Q1 EPS by 1c, Comps Increase 1.7%, Offers Q2 & FY15 Guidance
June 3, 2015 4:10 PM EDTFive Below (NASDAQ: FIVE) reported Q1 EPS of $0.08, $0.01 better than the analyst estimate of $0.07. Revenue for the quarter came in at $153.7 million versus the consensus estimate of $151.41 million. Comparable store sales increased by 1.7%.
Five Below sees Q2 2015 EPS of $0.12-$0.13, versus the consensus... More
Trading Radar for 6/3: Vera Bradley (VRA), Verint Systems (VRNT), Five Below (FIVE), Brown Forman (BF-A) Report
June 2, 2015 2:46 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:15am EDT
8:30am EDT
Trade Balance - Street sees... More